Innovation Hub / Podcasts
Weekly News Roundup - Neurodegeneration Deals, Generative AI, and Drug Pricing Politics
January 16, 2026
This week's tHEORetically Speaking News Roundup covers Novartis' $1.5B Alzheimer's licensing deal, the FDA's push to accelerate drug development through Bayesian trial methods, and Bayer's move to scale generative AI in antibody discovery. We also break down Oxford Biomedica's takeover talks and a newly unveiled US healthcare cost plan.
Weekly News Roundup - PhRMA Leadership Transition, The ICHRA Shift, and MDUFA VI Preliminary Deal
Talking Real Science with Stella Goulopoulou
Talking Real Science with Yelena Akelina
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8+ T Cell Co-culture Experiments
Talking Real Science with Licy Yanes Cardozo
Industry Insights with Bas Trietsch and STEMCELL Technologies
Talking Real Science with Helen Collins
Talking Real Science with Rachel Buckley
Talking Real Science with Meaghan Loy on Rare Disease Day